What is the action of meropenem?

Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death.

When should you not use meropenem?

Who should not take MEROPENEM?

• diarrhea from an infection with Clostridium difficile bacteria.
• decreased blood platelets.
• lesion of the brain.
• seizures.
• chronic kidney disease stage 4 (severe)
• chronic kidney disease stage 5 (failure)
• kidney disease with likely reduction in kidney function.

What type of medicine is meropenem?

Meropenem is used to treat a wide variety of bacterial infections. This medication is known as a carbapenem-type antibiotic. It works by stopping the growth of bacteria.

What is the generic name for meropenem?

Meropenem, sold under the brandname Merrem among others, is an intravenous β-lactam antibiotic used to treat a variety of bacterial infections. Some of these include meningitis, intra-abdominal infection, pneumonia, sepsis, and anthrax.

What are the side effects of meropenem?

Common side effects of meropenem are: Injection site pain and inflammation. Rash. Constipation. Diarrhea. Nausea. Vomiting. Headache.

What is meropenem prescribed for?

Meropenem is an antibiotic that fights bacteria. Meropenem is used to treat severe infections of the skin or stomach. Meropenem is also used to treat bacterial meningitis (infection of brain or spinal cord). Meropenem may also be used for purposes not listed in this medication guide.

Is meropenem an effective medication for UTI?

Meropenem-vabobactam, a combination carbapenem/beta-lactamase inhibitor, is more effective than piperacillin-tazobactam at treating complicated urinary tract infections ( UTIs ), according to a new study.

What conditions does meropenem vial treat?

Meropenem is frequently given in the treatment of febrile neutropenia. This condition frequently occurs in patients with hematological malignancies and cancer patients receiving anticancer drugs that suppress bone marrow formation.